How did SLN's earnings per share perform in Q3 2023?
4/3/2025 05:14pm
Silence Therapeutics (SLN) reported a negative diluted EPS of $0.09 for Q3 2023, reflecting a loss for the period.
|code|Ticker|Name|Date|Diluted EPS YoY|Diluted EPS|market_code|
|---|---|---|---|---|---|---|
|SLN|SLN.O|Silence Therapeutics|2023 Q1|-3.888611865557625|-0.1175055|185|
|SLN|SLN.O|Silence Therapeutics|2023 Q2|24.573149697133807|-0.1220064|185|
|SLN|SLN.O|Silence Therapeutics|2023 Q3|-12.747240684190569|-0.0903836|185|